General Information of the Compound
Compound ID
CP0403423
Compound Name
4-Pyridazin-3-yl-piperazine-1-carboxylic acid (6-fluoro-benzothiazol-2-yl)-amide
    Show/Hide
Structure
Formula
C16H15FN6OS
Molecular Weight
358.402
Canonical SMILES
Fc1ccc2nc(NC(=O)N3CCN(CC3)c3cccnn3)sc2c1
    Show/Hide
InChI
InChI=1S/C16H15FN6OS/c17-11-3-4-12-13(10-11)25-15(19-12)20-16(24)23-8-6-22(7-9-23)14-2-1-5-18-21-14/h1-5,10H,6-9H2,(H,19,20,24)
    Show/Hide
InChIKey
HRYARCJPLFCEKV-UHFFFAOYSA-N
Physicochemical Property
logP
2.5795
Rotatable Bonds
2
Heavy Atom Count
25
Polar Areas
74.25
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
25

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44396081
ChEMBL ID
CHEMBL186446
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS